Here are four notes:
1. Among analysts covering the shares, the 12-month average price target totals $48.50.
2. On Dec. 5, 2016, TheStreet increased SCA’s rating from a “hold” to a “buy” rating.
3. SCA shares have a 50-day moving average of $52.18 and 200-day moving average of $46.60.
4. The company’s market cap totals $2.28 billion.
More articles on surgery centers:
Bay Area Regional Medical Center, Medistar team up on ASC — 4 things to know
SurgCenter Development opens 12th center in Florida; AmSurg earnings per share total $1.13 in Q3 & more — 5 ASC company notes
SurgCenter of St. Lucie opens its doors: 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
